1. Home
  2. BAC vs NVO Comparison

BAC vs NVO Comparison

Compare BAC & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of America Corporation

BAC

Bank of America Corporation

HOLD

Current Price

$55.87

Market Cap

380.6B

Sector

Finance

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$43.92

Market Cap

197.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAC
NVO
Founded
1784
1923
Country
United States
Denmark
Employees
213000
69500
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.6B
197.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BAC
NVO
Price
$55.87
$43.92
Analyst Decision
Buy
Hold
Analyst Count
20
11
Target Price
$60.34
$51.00
AVG Volume (30 Days)
34.9M
11.4M
Earning Date
04-15-2026
05-06-2026
Dividend Yield
2.12%
3.19%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.11
N/A
Revenue Next Year
$5.80
$3.70
P/E Ratio
$14.01
$13.60
Revenue Growth
N/A
N/A
52 Week Low
$44.06
$35.12
52 Week High
$57.55
$71.80

Technical Indicators

Market Signals
Indicator
BAC
NVO
Relative Strength Index (RSI) 71.59 51.97
Support Level $51.20 $43.35
Resistance Level $57.21 $50.30
Average True Range (ATR) 1.15 1.38
MACD 0.42 -0.12
Stochastic Oscillator 85.61 56.85

Price Performance

Historical Comparison
BAC
NVO

About BAC Bank of America Corporation

Bank of America is a formidable financial titan with a $3.5 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: